TFEB and cardiac hypertrophy: In line with our data are findings from Kenny et al. (2021), who showed that TFEB overexpression at higher levels (8-fold increase in TFEB) in cardiomyocytes promoted pathological cardiac hypertrophy, suppressed mitochondrial and activated pro-fibrotic pathways (59).